m2m Imaging Corporation
m2m Imaging Corp. (“m2m”) was formed by the acquisition of Spin Systems Pty Ltd (Australia) by Supertron Technologies, Inc. m2m specialises in developing high performance magnetic resonance imaging (“MRI”) coils and accessories that allow for enhanced imaging for clinical and preclinical markets without escalating costs. Ultimately, enhanced images are necessary for better disease detection and faster drug discovery. This need has created a strong demand for solutions, such as the cryogenic coil, that enable better images without creating added cost.
Magnetic Resonance (“MR”) based applications are growing rapidly, fueled by the market’s growth and insatiable demand for new therapeutic applications and solutions. The continuing growth of the global installed base of clinical and preclinical MR systems continues to provide m2m enormous opportunities for growth and it is estimated that the market is valued at US $12 billion.
Amphion’s fully-diluted ownership stake in m2m was 23.53% as of 31 December 2007, valued at US $4.0 million (2006: US $3.7 million).
Management
C. Richard Hullihen – Chief Executive Officer
Erzhen Gao, Ph.D. – Chief Scientist
Cameron Barnard – Marketing and Business Development Manager
Board of Directors
Robert J. Bertoldi, Chairman – President and Chief Financial Officer, Amphion Innovations plc
Thomas Blum – Managing Director, GC Andersen Partners LLC
C. Richard Hullihen – Chief Executive Officer, m2m Imaging Corporation
Raymond McKenzie – Partner, Geninvest
Daniel Rice – President and Chief Executive Officer, Mayport Venture Partners
Zev Rosenzweig – Retired Vice President, Military Aviation Training for Bombardier, Inc.
